Outer Membrance Protein vaccinogens of Treponema pallium
梅毒螺旋体外膜蛋白疫苗原
基本信息
- 批准号:10618189
- 负责人:
- 金额:$ 90.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAlgorithmsAntibodiesAntigensArchitectureBioinformaticsBiological AssayC-terminalCatalogsContainmentDataDiseaseEpidemiologyEscherichia coliFamilyFormulationGeneticGenomeGenomicsGram-Negative BacteriaHumanImmuneImmune EvasionImmune SeraImmunizationInfectionLaboratoriesLipoproteinsMacrophageMembraneMembrane ProteinsMembrane Transport ProteinsMolecularMolecular ChaperonesMolecular MachinesMusOrder SpirochaetalesOryctolagus cuniculusPathogenicityPatientsPeriplasmic ProteinsPopulationProteinsResearch PersonnelResistanceSerumSexually Transmitted DiseasesSocietiesStructural ModelsSurfaceSurface AntigensSyphilisTestingTranslatingTreponemaTreponema pallidumTreponema pallidum subspecies pallidumUnited StatesVaccine DesignVaccinesVertical Disease Transmissionadverse pregnancy outcomeamphiphilicityantigen testbiophysical analysiscross immunityfallsmembermennovelparalogous genepathogenphysical propertysexsyphilis vaccinevaccine candidatevaccine developmentvaccinology
项目摘要
Syphilis, a sexually transmitted infection caused by the Treponema pallidum subsp. pallidum (TPA), has
undergone a dramatic resurgence in the United States since the late 1990s. Syphilis also poses a major threat
globally with an estimated 5.6 million new cases annually and 350,000 adverse pregnancy outcomes due to
mother-to-child transmission. There is a growing sense of urgency about the need for a syphilis vaccine as a
cornerstone of a strategy for global containment. Our quest to develop a syphilis vaccine began with the
recognition that the outer membrane (OM) of TPA differs fundamentally from those of prototypical Gram-
negative bacteria, such as E. coli. We hypothesized that TPA's `unorthodox' OM is the basis for its impressive
capacity for immune evasion and that identification of TPA's repertoire of rare OM-spanning proteins (OMPs)
holds the key to vaccine development.
The ability of all previously tested antigens to confer at best only limited protection suggests that a syphilis
vaccine will require multiple components and, consequently, the need for a pipeline of candidate vaccinogens to
identify the combination that provides the greatest breadth and degree of local and systemic protection. Despite
the availability of genomic sequences, until recently, syphilologists were unable to catalog the spirochete's
`OMPeome'. The breakthrough came by using bioinformatics, computational, and structural algorithms to mine
the TPA genome for proteins predicted to form an amphiphilic b-barrel, the structural hallmark of OM-spanning
proteins. With this approach, we identified 20 candidate OMPs in TPA, which fall into two `classes': Tprs and a
group of unrelated (`non-Tpr') b-barrel-forming proteins. For several (TP0326/BamA and members of Tpr
subfamily I), b-barrel formation and OM localization in TPA has been validated by rigorous experimentation,
and their ability to elicit potent opsonic activity also has been demonstrated. Our proposal takes the notion of
`opsonic target as protective antigen' in an unbiased and novel direction: leading candidate OMP vaccinogens
are selected based on genomic sequences, bioinformatics, biophysical analysis, and structural modeling, rather
than whether they are recognized by immune sera generated during infection. Our pipeline consists of OMPs
from four `groups': BamA, subfamily I and II Tprs, and the FadLs. In Aim 1, we will refine our topological and
structural models for leading candidates in the Tpr subfamilies and FadL groups. In Aim 2, we will assess whether
high titer antisera against one or more candidate OMPs promote opsonophagocytosis of TPA (an ex vivo
correlate of protection) using rabbit and mouse macrophages. In Aim 3, we will determine in rabbits, and in
exploratory studies with mice, if immunization with one or more OMPs provides broad as well as strong
protection following challenge with diverse strains of TPA.
梅毒,一种由梅毒螺旋体亚种引起的性传播感染。苍白球(TPA)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin D Radolf其他文献
Justin D Radolf的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin D Radolf', 18)}}的其他基金
Outer Membrance Protein vaccinogens of Treponema pallium
梅毒螺旋体外膜蛋白疫苗原
- 批准号:
10399446 - 财政年份:2019
- 资助金额:
$ 90.97万 - 项目类别:
Outer Membrance Protein vaccinogens of Treponema pallium
梅毒螺旋体外膜蛋白疫苗原
- 批准号:
10765597 - 财政年份:2019
- 资助金额:
$ 90.97万 - 项目类别:
2014 Biology of Spirochetes Gordon Research Conference & Gordon Research Seminar
2014年螺旋体生物学戈登研究会议
- 批准号:
8613696 - 财政年份:2014
- 资助金额:
$ 90.97万 - 项目类别:
RpoS Regulation of Borrelia burgdorferi Genes in vivo
伯氏疏螺旋体基因的体内 RpoS 调控
- 批准号:
8055723 - 财政年份:2010
- 资助金额:
$ 90.97万 - 项目类别:
CRYOELECTRON TOMOGRAPHIC ANALYSIS OF TREPONEMA PALLIDUM
梅毒螺旋体的冷电子断层扫描分析
- 批准号:
8172285 - 财政年份:2010
- 资助金额:
$ 90.97万 - 项目类别:
CRYOELECTRON TOMOGRAPHIC ANALYSIS OF TREPONEMA PALLIDUM
梅毒螺旋体的冷电子断层扫描分析
- 批准号:
7954590 - 财政年份:2009
- 资助金额:
$ 90.97万 - 项目类别:
CUTANEOUS IMMUNE RESPONSE IN LYME DISEASE AND SECONDARY SYPHILIS
莱姆病和二期梅毒的皮肤免疫反应
- 批准号:
7719087 - 财政年份:2008
- 资助金额:
$ 90.97万 - 项目类别:
CRYOELECTRON TOMOGRAPHIC ANALYSIS OF TREPONEMA PALLIDUM
梅毒螺旋体的冷电子断层扫描分析
- 批准号:
7721722 - 财政年份:2008
- 资助金额:
$ 90.97万 - 项目类别:
相似海外基金
DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
- 批准号:
EP/Y029089/1 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
- 批准号:
2337776 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
- 批准号:
2338846 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
- 批准号:
2348261 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
- 批准号:
2348346 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
- 批准号:
2339310 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
- 批准号:
2339669 - 财政年份:2024
- 资助金额:
$ 90.97万 - 项目类别:
Continuing Grant














{{item.name}}会员




